ScoreWhy is Hangzhou Biotest Biotech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -38.86% and Operating profit at -63.30% over the last 5 years
2
With a fall in Net Sales of -13.84%, the company declared Very Negative results in Sep 25
- DEBT-EQUITY RATIO (HY) Highest at -65.15 %
- NET PROFIT(Q) At CNY 9.86 MM has Fallen at -42.12%
- DEBTORS TURNOVER RATIO(HY) Lowest at 5.54 times
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hangzhou Biotest Biotech Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Hangzhou Biotest Biotech Co., Ltd.
15.11%
1.16
65.49%
China Shanghai Composite
16.01%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-38.86%
EBIT Growth (5y)
-63.30%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.21
Tax Ratio
15.45%
Dividend Payout Ratio
92.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
119.24%
ROE (avg)
13.43%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
56
Industry P/E
Price to Book Value
2.56
EV to EBIT
72.98
EV to EBITDA
54.31
EV to Capital Employed
5.52
EV to Sales
9.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.56%
ROE (Latest)
4.60%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 3.19 times
-21What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -65.15 %
NET PROFIT(Q)
At CNY 9.86 MM has Fallen at -42.12%
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.54 times
NET SALES(Q)
Fallen at -13.84%
PRE-TAX PROFIT(Q)
Fallen at -38.2%
Here's what is working for Hangzhou Biotest Biotech Co., Ltd.
Inventory Turnover Ratio
Highest at 3.19 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for Hangzhou Biotest Biotech Co., Ltd.
Net Profit
At CNY 9.86 MM has Fallen at -42.12%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Debt-Equity Ratio
Highest at -65.15 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Net Sales
Fallen at -13.84%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Pre-Tax Profit
Fallen at -38.2%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Debtors Turnover Ratio
Lowest at 5.54 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
